| 09.00 |
Keynote Lecture Reprogramming the Genetic Code Jason W. Chin, Cambridge Biomedical Campus, Cambridge, GB |
|---|---|
| 09.40 |
RNA functionalization via an expanded genetic alphabet Stephanie Kath-Schorr, Rheinische Friedrich-Wilhelms-Universität Bonn, D |
| 10.00 |
Chemoenzymatic cascade for the synthesis of hydroxytriazenes Alvaro Gómez Baraibar, Ruhr Universität Bochum, D |
| 10.20 |
Framework Rearrangements in the Synthesis of Bioactive abeo-Steroids Philipp Heretsch, Freie Universität Berlin, D |
| 10.40 |
Synthetic natural products for bioactivity studies: aurantizolicin and parthenolide Hans-Dieter Arndt, Universität Jena, D |
| 11.00 | COFFEE BREAK |
| 11.20 |
The power of chemoselectivity: Powerful conjugation technologies for next-generation ADCs Christian Hackenberger, FMP Berlin, D |
| 11.40 |
Mapping Methyltransferase Target Sites in RNA Andrea Rentmeister, Westfälische Wilhelms-Universität Münster, D |
| 12.00 |
Live-cell profiling for inhibitors of quinolone biosynthesis Thomas Böttcher, Universität Konstanz, D |
| 12.20 |
Designed macrocyclic peptides as nanomolar inhibitors of amyloid self-assembly in Alzheimer's disease and type 2 diabetes Aphrodite Kapurniotu, TU Munich, München, D |
| 12.40 | LUNCH BREAK |
| 13.40 |
Poster Award |
| 13.45 |
Keynote Lecture A Semi-synthetic organism that stores and retrieves increased genetic information Floyd Romesberg, The Scripps Research Institute, La Jolla, US |
| 14.25 |
Translational Efforts Exploiting the Pathoblocker Concept: Lead Optimization of PqsR Antagonists for the Treatment of Chronic Pseudomonas aeruginosa Infections Martin Empting, Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Braunschweig, D |
| 14.45 |
6-TramTO-3 Enables in ViVo Interaction Studies of Multidrug-Resistant Pathogens and Host Cells Olalla Vázquez, Philipps-Universität Marburg, D |
| 15.05 |
Covalent inhibitor induced dimerization of an essential oxidoreductase from African Trypanosomes Ute Hellmich, Johannes Gutenberg-Universität Mainz, D |
| 15.25 |
Novel Secondary Metabolites from Microbial Symbionts Isolation, Synthesis and Bioactivity Studies Christine Beemelmanns, Leibniz-Institut für Naturstoff- Forschung und Infektionsbiologie e.V. - Hans-Knöll-Institut, Jena, D |
| 15.45 |
Closing and End of the Conference |
